Literature DB >> 7700242

Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.

M S Choudhary1, N Sachs, A Uluer, R A Glennon, R B Westkaemper, B L Roth.   

Abstract

In this paper we show that a highly conserved aromatic residue, phenylalanine at the 340-position, is essential for ergoline binding to 5-hydroxytryptamine2A receptors. We hypothesized that F340 was essential for a specific aromatic-aromatic interaction (e.g., pi-pi or hydrophobic) between the phenyl moiety of F340 and the aromatic ring of the ergoline nucleus. To test this hypothesis, eight point mutations of adjacent (F340 and F339) and nonadjacent (F125) phenylanaines were made, using conservative (phenylalanine to tyrosine) and nonconservative (phenylalanine to leucine, alanine, or serine) substitutions. The binding affinities of all of the tested simple ergolines were greatly reduced by specific mutations of F340 in which aromatic-aromatic interactions (e.g., F340A and F340L) were abolished, but they were unaffected when the replacement residue was aromatic (e.g., F340Y). In contrast, the binding affinities of four ergopeptines (bromocryptine, ergocryptine, ergocornine, and ergotamine) were relatively unaffected by the F340L substitution. Neither ergoline nor ergopeptine affinities were consistently altered by F339 mutations. These results support the notion that aromatic-aromatic interactions (either pi-pi of hydrophobic) with F340 are essential for the binding of simple ergolines but not ergopeptines to 5-hydroxytryptamine2A receptors. Our findings support models of ergoline and ergopeptine binding to serotonin receptors that suggest that the nature of the substituent at the 8-position of the ergoline nucleus may give rise to different modes of binding for the two classes of agents, particularly with respect to the phenyl ring of F340.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700242

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

Review 1.  Structural organization of G-protein-coupled receptors.

Authors:  A L Lomize; I D Pogozheva; H I Mosberg
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

2.  Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor.

Authors:  Maria Elena Silva; Ralf Heim; Andrea Strasser; Sigurd Elz; Stefan Dove
Journal:  J Comput Aided Mol Des       Date:  2010-11-19       Impact factor: 3.686

Review 3.  Structure and function of serotonin G protein-coupled receptors.

Authors:  John D McCorvy; Bryan L Roth
Journal:  Pharmacol Ther       Date:  2015-01-17       Impact factor: 12.310

4.  Computational model of the complex between GR113808 and the 5-HT4 receptor guided by site-directed mutagenesis and the crystal structure of rhodopsin.

Authors:  M L López-Rodríguez; M Murcia; B Benhamú; M Olivella; M Campillo; L Pardo
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

5.  Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

Authors:  Clinton E Canal
Journal:  Handb Exp Pharmacol       Date:  2018

6.  Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.

Authors:  Małgorzata Dukat; Philip D Mosier; Renata Kolanos; Bryan L Roth; Richard A Glennon
Journal:  J Med Chem       Date:  2008-01-18       Impact factor: 7.446

7.  Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists.

Authors:  Thibault Varin; Hugo Gutiérrez-de-Terán; Marián Castro; José Brea; Frederic Fabis; François Dauphin; Johan Aqvist; Alban Lepailleur; Pilar Perez; Javier Burgueño; José Miguel Vela; Maria Isabel Loza; Jordi Rodrigo
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

8.  Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.

Authors:  Jitesh R Shah; Philip D Mosier; Bryan L Roth; Glen E Kellogg; Richard B Westkaemper
Journal:  Bioorg Med Chem       Date:  2009-08-13       Impact factor: 3.641

9.  Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor.

Authors:  U Gether; S Lin; P Ghanouni; J A Ballesteros; H Weinstein; B K Kobilka
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

10.  Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.

Authors:  Scott P Runyon; Philip D Mosier; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Journal:  J Med Chem       Date:  2008-10-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.